Identification of WDFY3 neoantigens as prognostic markers in long-term survivors of extrahepatic cholangiocarcinoma.

CONCLUSION: We suggest that the WDFY3 neoantigens may affect prognosis by regulating antitumor immunity and that the WDFY3 neoantigens may be harnessed as potential targets for immunotherapy of EHCC.
PMID: 32957886 [PubMed - as supplied by publisher]

Source: Current Cancer Drug Targets - September 17, 2020 Category: Cancer & Oncology Authors: Wang Y, Jin B, Zhou N, Sun Z, Li J, Chen Q, Wu X, Zhou Y, Shi Y, Lu X, Sang X, Mao Y, Du S, Wang W, Bai C Tags: Curr Cancer Drug Targets Source Type: research